Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
J. Health Biol. Sci. (Online) ; 10(1): 1-6, 01/jan./2022. tab, ilus
Artículo en Inglés | LILACS | ID: biblio-1370924

RESUMEN

Objective: to evaluate the molecular interaction of silibinin with the targets ALS3 and SAP5. Methodology: Molecular docking protocols were conducted to analyze the binding interaction of silibinin with ALS3 and SAP5. Results: Eleven interactions of ALS3 with silibinin and four with fluconazole were found, while six interactions were observed of SAP5 with silibinin and four with fluconazole. Conclusion: Molecular docking between silibinin and ALS3 identified important interactions, but no significant interactions were observed with SAP5, even though silibinin can exhibit affinity and interactions with other SAP5 sites.


Objetivo: Avaliar a interação molecular da silibinina com os alvos ALS3 e SAP5. Metodologia: Protocolos de docking molecular foram conduzidos para analisar a interação de ligação da silibinina com ALS3 e SAP5. Resultados: Foram encontradas onze interações de ALS3 com silibinina e quatro com fluconazol, enquanto seis interações foram observadas de SAP5 com silibinina e quatro com fluconazol. Conclusão: Docking molecular entre silibinina e ALS3 identificou interações importantes, mas não foram observadas interações significativas com SAP5, embora a silibinina possa apresentar afinidade e interações com outros sítios SAP5.


Asunto(s)
Candida albicans , Silimarina , Proteínas , Infecciones Fúngicas Invasoras
2.
Int. j. morphol ; 38(1): 165-175, Feb. 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1056416

RESUMEN

An alternative hyper-ovulator inducer to replace clomiphene citrate (CC) is needed as it is unsuitable for women with polycystic ovarian syndrome and is associated with low pregnancy rates. Anastrozole is an effective hyper-ovulator inducer, but has not been well researched. In order to determine the effectiveness of anastrozole as a hyper-ovulator inducer and to an extent compare it with CC in similar situations, this study ascertained the effects of these drugs on the expression of the focal adhesion proteins, paxillin and FAK, which are uterine receptivity markers in the surface luminal uterine epithelial cells of day 1 and day 6 pregnant Wistar rats. The results show that paxillin is localized in focal adhesions at the base of the uterine epithelial cells at day 1 of pregnancy whereas at day 6, paxillin disassembles from the basal focal adhesions and localizes and increases its expression apically. FAK is faintly expressed at the basal aspect of the uterine epithelial cells while moderately expressed at the cell-to-cell contact at day 1 in all groups from where it disassembles and relocates apically and becomes more intensely expressed at day 6 of pregnancy in untreated and anastrozole treated rats. Although paxillin is localized apically at day 6, its expression is significantly down-regulated with CC treatment suggesting its interference with the implantation process. These findings seem to suggest that anastrozole could favor implantation.


Para reemplazar el citrato de clomifeno (CC) es necesario un inductor de hiperovulación alternativo, ya que no es adecuado para mujeres con síndrome de ovario poliquístico y está asociado con tasas bajas de embarazo. El anastrozol es un inductor eficaz del hiper-ovulador, pero no se ha investigado adecuadamente. Con el fin de determinar la efectividad del anastrozol como inductor del hiper-ovulador y, en cierta medida, compararlo con CC en situaciones similares, este estudio determinó los efectos de estos fármacos en la expresión de las proteínas de adhesión focal, paxillin y FAK, uterinas marcadores de receptividad en la superficie luminal de células uterinas epiteliales, del día 1 y día 6 en ratas Wistar preñadas. Los resultados muestran que la paxilina se localiza en adherencias focales en la base de las células epiteliales uterinas en el día 1 del embarazo, mientras que en el día 6, la paxilina se desmonta de las adherencias focales basales y localiza y aumenta su expresión apicalmente. FAK se expresa débilmente en el aspecto basal de las células epiteliales uterinas, mientras que se expresa moderadamente en el contacto de célula a célula en el día 1 en todos los grupos, donde se separa y se reubica apicalmente y se expresa con mayor intensidad el día 6 de la preñez, en pacientes no tratados y tratados. ratas tratadas con anastrozol. Aunque la paxillina se localiza apicalmente en el día 6, su expresión está significativamente disminuida con el tratamiento con CC, lo que sugiere su interferencia con el proceso de implantación. Estos hallazgos sugieren que el anastrozol podría favorecer el proceso de implantación.


Asunto(s)
Animales , Femenino , Ratas , Útero/efectos de los fármacos , Anastrozol/farmacología , Ovulación/efectos de los fármacos , Ratas Wistar , Adhesiones Focales/efectos de los fármacos , Epitelio/efectos de los fármacos , Proteína-Tirosina Quinasas de Adhesión Focal/efectos de los fármacos , Paxillin/efectos de los fármacos , Reacción en Cadena en Tiempo Real de la Polimerasa , Microscopía Fluorescente
3.
Int. j. morphol ; 36(1): 345-357, Mar. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-893233

RESUMEN

SUMMARY: An alternative superovulator to replace clomiphene citrate is needed as clomiphene citrate is associated with low pregnancy rates. Anastrozole is an effective superovulator, but it has not been well researched. In order to determine the effectiveness of anastrozole as a superovulator and to compare it with clomiphene citrate in similar situations, this study ascertained the effects of these drugs on the expression of the focal adhesion proteins, vinculin and integrin β5, which are uterine receptivity markers, in the uterine epithelial cells of day 1 and day 6 pregnant Wistar rats. The results show that vinculin and integrin β5 are co-localized at the base of the uterine epithelium at day 1 of pregnancy whereas at day 6, they disassemble from the basal focal adhesions and co-localize and significantly increase their expression apically (p≤0.0001). Moreover, there is a significant difference in the protein expression levels of vinculin and integrin b5 in uterine luminal epithelial cells between untreated (control) and chlomiphene citrate treated rats (p≤0.0001), anastrozole and chlomiphene citrate treated rats at day 6 (p≤0.0001) suggesting the interpretation that anastrozole seems to enhance their expression in order to perhaps assist in the implantation process of the blastocyst. The immunofluorescence experiments agree with the vinculin and integrin β5 gene expression findings in which at day 6 of pregnancy, vinculin and integrin β5 gene expression are significantly upregulated in uterine luminal epithelial cells in the anastrozole treated group relative to the calibrator sample (p≤0.0001). These findings suggest that anastrozole is implantation friendly.


RESUMEN: Es necesario un superovulador alternativo para reemplazar el citrato de clomifeno, debido a que está asociado con bajas tasas de preñez. El anastrozol es un superovulador eficaz, sin embargo es poca su investigación. Con el fin de determinar la efectividad del anastrozol como superovulador y compararlo con citrato de clomifeno en situaciones similares, se determinaron los efectos de estos fármacos sobre la expresión de las proteínas de adhesión focal, vinculina e integrina β5, en marcadores de receptividad uterina en días 1 y 6, en las células epiteliales uterinas de ratas Wistar preñadas. Los resultados muestran que la vinculina y la integrina β5 se co-localizan en la base del epitelio uterino al día 1 de la gravidez mientras que al día 6 se desmontan de las adherencias focales basales, co-localizan y aumentan significativamente su expresión apicalmente (p≤0.0001). Además, existe una diferencia significativa en los niveles de expresión de proteína de vinculina e integrina β5 en células epiteliales luminales uterinas entre ratas no tratadas (control) y tratadas con citrato declomifeno (p≤0.0001), ratas tratadas con anastrozol y citrato declomifeno al día 6 (p≤0,0001) sugiriendo la interpretación de que el anastrozol parece mejorar su expresión con el fin de ayudar en el proceso de implantación del blastocisto. Los experimentos de inmunofluorescencia coinciden con los resultados de la expresión de los genes vinculina e integrina β5 en los cuales al día 6 de la preñez, la vinculina y la integrina β5 están significativamente reguladas en células epiteliales luminales uterinas en el grupo tratado con anastrozol con respecto a la muestra del calibrador (p<0,0001). Estos hallazgos sugieren que el anastrozol es favorable para la implantación.


Asunto(s)
Animales , Femenino , Embarazo , Ratas , Integrinas/efectos de los fármacos , Nitrilos/farmacología , Triazoles/farmacología , Útero/efectos de los fármacos , Vinculina/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Adhesiones Focales/efectos de los fármacos , Integrinas/genética , Integrinas/fisiología , Microscopía Confocal , Microscopía Fluorescente , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Vinculina/genética , Vinculina/fisiología
4.
Journal of Lung Cancer ; : 113-121, 2004.
Artículo en Inglés | WPRIM | ID: wpr-65607

RESUMEN

PURPOSE: We investigated the effect of macrolides on the extracellular matrix (ECM) invasion and expression of cell adhesion proteins in non-small cell lung cancer cells. MATERIALS AND METHODS: Three kinds of macrolides, azithromycin, erythromycin and clarithromycin were treated in several human Non-Small Cell Lung Cancer (NSCLC) cell lines at doses from 0.1 to 1.5microg/ml. ECM invasion was measured by an in vitro chemo-invasion assay using matrigel-coated invasion chambers. RESULTS: Azithromycin inhibited the migration of NCI-H157 and NCI-H1299 cell lines. Erythromycin inhibited the migration of NCI-H157 and NCI-H2066, and clarithromycin had inhibitory effects on the migration of NCI-H358 and NCI-H2009. These results indicate that macrolides inhibit the ECM invasion of the tested NSCLC cells cell line-specifically. Western blot analyses for cell adhesion proteins (CAPs) showed that these were up-regulated by treatment with macrolides in some of the NSCLC cell lines. Based on the results of chemo-invasion assay, we selected each 2-cell line group, one was significantly suppressed by AM (NCI-H157 and NCI-H1299) and the other was less effectively suppressed by EM (NCI-H358 and NCI-H460). The expression levels of cell adhesion proteins increased in a dose-dependent manner in two cell lines in which their ECM invasion was inhibited by AM, however, the other two cell lines showed unchanged expression levels even at higher doses. Furthermore, the expressions of E1AF and matrix metalloproteinases (MMPs) activity were examined by RT-PCR and gelatin zymography, respectively with the selected 4 cell lines. E1AF expression level was found to decrease from the basal level in NCI-H157 and the activity of MMP-9 was also shown to decrease in NCI-H157 and NCI-H1299. Cell adhesion to fibronectin was a little reduced in NCI-H157 from its basal level. CONCLUSION: Consequently, the present study suggests that macrolides inhibit the ECM invasion of NSCLC cells by inducing the altered expression of cell adhesion proteins


Asunto(s)
Humanos , Azitromicina , Western Blotting , Carcinoma de Pulmón de Células no Pequeñas , Adhesión Celular , Línea Celular , Claritromicina , Eritromicina , Matriz Extracelular , Fibronectinas , Gelatina , Macrólidos , Metaloproteinasas de la Matriz
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA